Filing Details

Accession Number:
0001415889-21-005860
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-12-14 16:03:49
Reporting Period:
2021-12-10
Accepted Time:
2021-12-14 16:03:49
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1750284 Olema Pharmaceuticals Inc. OLMA Pharmaceutical Preparations (2834) 300409740
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1831216 C. David Myles C/O Olema Pharmaceuticals, Inc.
512 2Nd Street, 4Th Floor
San Francisco CA 94107
Chief Development Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-12-10 10,000 $10.30 582,901 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 12,831 Indirect See Footnote
Common Stock 154,846 Indirect See Footnote
Footnotes
  1. T he weighted average sale price for the transaction reported was $10.30, and the range of prices was between $10.23 and $10.50. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.
  2. Includes 589 shares acquired under the issuer's Employee Stock Purchase Plan on May 14, 2021, and 491 shares acquired under the issuer's Employee Stock Purchase Plan on November 15, 2021.
  3. The shares are held by The Myles Family Revocable Inter Vivos Trust, of which the Reporting Person is trustee.
  4. The shares are held by Myles Properties Inc., of which the Reporting Person is President.